From: Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Frequency
%
Esophagitis
14
58.3
G1
7
29.2
G2
5
20.8
G3
2
8.3
Pneumonitis G1
1
4.2
Hematological toxicity
3
12.5